As of 2026-03-31, 阿莫西林's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 0.3 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 阿莫西林's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
阿莫西林's Mention Rate is 0.00%, lower than 0.6% of competitors
阿莫西林's First Mention is 0.00%, lower than 0.9% of competitors
阿莫西林's Preferred Rate is 0.00%, lower than 100.0% of competitors
阿莫西林's Positive Rate is 0.00%, lower than 8.9% of competitors
阿莫西林's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 板板蓝根颗粒 | 2.7% | 0% | 0% | 2.7% | 0% | View Details |
| 板板蓝根 | 2.7% | 0% | 0% | 0% | 0% | View Details |
| ZZithromax | 0% | 0% | 0% | 0% | 0% | View Details |
| 孚孚诺 | 0% | 0% | 0% | 0% | 0% | View Details |
| 布布洛芬 | 0% | 0% | 0% | 0% | 0% | View Details |
| 安安宫牛黄丸 | 0% | 0% | 0% | 0% | 0% | View Details |
| 阿阿莫西林 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
